Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

NCT01414608 is registered in ClinicalTrials.gov with GOG Foundation as lead sponsor.

NCT NCT01414608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01414608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Lead sponsor
GOG Foundation
Phase
Phase 3
Overall status
Completed
Start date
January 9, 2012
Completion date
July 9, 2021
Enrollment
926 (actual)
Sites
326

Conditions

As the registry lists them; a condition with its own page is linked.

cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical squamous cell carcinoma, not otherwise specified, stage ib cervical cancer ajcc v6 and v7, stage iia cervical cancer ajcc v7, stage iib cervical cancer ajcc v6 and v7, stage iiib cervical cancer ajcc v6 and v7, stage iva cervical cancer ajcc v6 and v7